Accentia Biopharmaceuticals, Inc. and Biostem U.S. Corp. Face Trading Suspension

Summary

Accentia Biopharmaceuticals, Inc. and Biostem U.S. Corp. have been ordered to suspend trading by a regulatory body, likely due to concerns over their financial stability or compliance with securities regulations.